Get startedLog in
    Picture of Voyager Therapeutics logo

    VYGR — Voyager Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSucker Stock
    All News

    Brief: Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

    Picture of Voyager Therapeutics logoVoyager Therapeutics
    20/11/2024 12:13
    Nov 20 (Reuters) - Voyager Therapeutics Inc  VYGR.O :
    * VOYAGER SELECTS TAU SILENCING GENE THERAPY DEVELOPMENT
CANDIDATE
FOR ALZHEIMER’S DISEASE
    * VOYAGER THERAPEUTICS : CANDIDATE VY1706 DEMONSTRATES
SIGNIFICANT
REDUCTIONS OF TAU AT LOW DOSES IN NHP STUDY; IND & CTA FILINGS
ANTICIPATED IN 2026

Source text:  ID:nGNX1lW7f1 
Further company coverage:  VYGR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Voyager Therapeutics

    See all news